Literature DB >> 11117842

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.

W Stummer1, A Novotny, H Stepp, C Goetz, K Bise, H J Reulen.   

Abstract

OBJECT: It has been established that 5-aminolevulinic acid (5-ALA) induces the accumulation of fluorescent porphyrins in glioblastoma multiforme (GBM), a phenomenon potentially exploitable to guide tumor resection. In this study the authors analyze the influence of fluorescence-guided resection on postoperative magnetic resonance (MR) imaging and survival in a series of patients who underwent surgery in the authors' department.
METHODS: Fifty-two consecutive patients with GBM received oral doses of 5-ALA (20 mg/kg body weight) 3 hours before induction of anesthesia. Intraoperatively, tumor fluorescence was visualized using a modified operating microscope. Fluorescing tissue was removed whenever it was considered safely possible. Residual enhancement on early postoperative MR imaging was quantified and related to each patient's characteristics to determine which factors influenced resection. Survival was analyzed using the Kaplan-Meier method and multivariate analysis was performed in which the Karnofsky Performance Scale (KPS) score, residual fluorescence, patient age, and residual enhancement on MR images were considered. Intraoperatively, two fluorescence qualities were perceived: solid fluorescence generally reflected coalescent tumor, whereas vague fluorescence mostly corresponded to infiltrative tumor. Complete resection of contrast-enhancing tumor was accomplished in 33 patients (63%). Residual intraoperative tissue fluorescence left unresected for safety reasons predicted residual enhancement on MR images in 18 of the 19 remaining patients. Age, residual solid fluorescence, and absence of contrast enhancement in MR imaging were independent explanatory factors for survival, whereas the KPS score was significant only in univariate analysis. No perioperative deaths and one case of permanent morbidity were encountered.
CONCLUSIONS: The observations in this study indicate the usefulness of 5-ALA-induced tumor fluorescence for guiding tumor resection. The completeness of resection, as determined intraoperatively from residual tissue fluorescence, was related to postoperative MR imaging findings and to survival in patients suffering from GBM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117842     DOI: 10.3171/jns.2000.93.6.1003

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  244 in total

1.  Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Authors:  Georg Widhalm; Georgi Minchev; Adelheid Woehrer; Matthias Preusser; Barbara Kiesel; Julia Furtner; Aygül Mert; Antonio Di Ieva; Boguslaw Tomanek; Daniela Prayer; Christine Marosi; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  Neurosurg Rev       Date:  2012-03-10       Impact factor: 3.042

2.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

3.  High-sensitive fluorescence endoscope using electrocardiograph-synchronized multiple exposure.

Authors:  Takehiro Ando; Kazuhiro Taniguchi; Hongho Kim; Sanghyun Joung; Etsuko Kobayashi; Hongen Liao; Shunei Kyo; Ichiro Sakuma
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-16       Impact factor: 2.924

Review 4.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  Protoporphyrin IX fluorescence contrast in invasive glioblastomas is linearly correlated with Gd enhanced magnetic resonance image contrast but has higher diagnostic accuracy.

Authors:  Kimberley S Samkoe; Summer L Gibbs-Strauss; Harold H Yang; S Khan Hekmatyar; P Jack Hoopes; Julia A O'Hara; Risto A Kauppinen; Brian W Pogue
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

Review 6.  5-aminolevulinic acid induced protoporphyrin IX (ALA-PpIX) fluorescence guidance in meningioma surgery.

Authors:  Pablo A Valdes; Matthias Millesi; Georg Widhalm; David W Roberts
Journal:  J Neurooncol       Date:  2019-01-02       Impact factor: 4.130

7.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Authors:  James S Cordova; Eduard Schreibmann; Costas G Hadjipanayis; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Chad A Holder
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

8.  Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach.

Authors:  N Sandow; W Klene; U Elbelt; C J Strasburger; P Vajkoczy
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

9.  Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.

Authors:  Hirohito Yano; Noriyuki Nakayama; Naoyuki Ohe; Kazuhiro Miwa; Jun Shinoda; Toru Iwama
Journal:  J Neurooncol       Date:  2017-04-21       Impact factor: 4.130

10.  ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Steen J Madsen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.